Skip to main content

Advertisement

SpringerLink
Log in

A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Emphysematous pyelonephritis (EPN) is an acute, severe necrotising infection of the kidney. There has been a shift from early nephrectomy to conservative methods. We conducted a meta-analysis to assess the impact of risk factors and treatment choices on outcomes in EPN.

Methods

We conducted a database search of all studies in English, reporting more than 12 patients of EPN from 1980 to 2020. We compiled the demographics, clinical presentations, risk factors, critical diagnostic results, treatment modalities and outcomes, including mortality.

Results

We identified 37 observational studies, 32 retrospective and 5 prospective. The studies reported on 1146 patients, of which 790(68.9%) were female, and 946 (82.5%) were diabetic. In addition, 184 (16.1%) patients had stones, and 235 (20.5%) had obstructive uropathy. Fever and flank pain were the most frequent symptoms. The most common clinical features were pyuria, fever, flank tenderness, and tachycardia. E. coli, Klebsiella pneumoniae and Proteus were the most frequent organisms isolated. X-ray KUB and ultrasound were used as initial diagnostic modalities, but CT scan was the usual diagnostic and confirmatory investigation. Confusion, shock, thrombocytopenia, sepsis, emergency nephrectomy and hyponatremia were significantly associated with mortality. In particular, confusion and hyponatremia were associated with a sevenfold increase in mortality risk. There was no evidence that diabetes, stones, obstructive uropathy, AKI or proteinuria was associated with higher mortality. Nevertheless, 143 of the total 1146 patients died (12.5%). While 26% of the patients who had upfront emergency nephrectomy died, only 9.7% and 10% of patients with medical management and medical management plus minimally invasive treatments died. However, patients that failed medical and minimally invasive treatments and needed salvage emergency nephrectomy had a mortality of upwards of 27%.

Conclusion

The risk factors for mortality in emphysematous pyelonephritis are shock, thrombocytopenia, confusion, hyponatremia and emergency nephrectomy. Conservative and minimally invasive treatment should be the initial management strategy for emphysematous pyelonephritis as they carry lesser mortality risks. The presence of risk factors may help predict the subset of patients who need aggressive treatment and minimally invasive treatment modalities or early nephrectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M (1984) Emphysematous pyelonephritis. J Urol 131(2):203–208. https://doi.org/10.1016/s0022-5347(17)50309-2

    Article  CAS  PubMed  Google Scholar 

  2. Wan YL, Lee TY, Bullard MJ, Tsai CC (1996) Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology 198(2):433–438. https://doi.org/10.1148/radiology.198.2.8596845

    Article  CAS  PubMed  Google Scholar 

  3. Huang JJ, Tseng CC (2000) Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160(6):797–805. https://doi.org/10.1001/archinte.160.6.797

    Article  CAS  PubMed  Google Scholar 

  4. Dutta P, Bhansali A, Singh SK, Gupta KL, Bhat MH, Masoodi SR, Kumar Y (2007) Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol Int 78(1):13–22. https://doi.org/10.1159/000096929 (PMID: 17192727)

    Article  PubMed  Google Scholar 

  5. Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, Ansari MS, Shrivastava A (2010) Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int 105(7):986–989. https://doi.org/10.1111/j.1464-410X.2009.08930.x

    Article  PubMed  Google Scholar 

  6. Aswathaman K, Gopalakrishnan G, Gnanaraj L, Chacko NK, Kekre NS, Devasia A (2008) Emphysematous pyelonephritis: outcome of conservative management [published correction appears in Urology. Urology 71(6):1007–1009. https://doi.org/10.1016/j.urology.2007.12.095

    Article  PubMed  Google Scholar 

  7. Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D (2009) Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 41(4):959–966. https://doi.org/10.1007/s11255-009-9552-y

    Article  PubMed  Google Scholar 

  8. Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC (1997) Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J Urol 157(5):1569–1573

    Article  CAS  Google Scholar 

  9. Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II (2007) Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol 178:880–885

    Article  Google Scholar 

  10. Boakes E, Batura D (2017) Deriving a management algorithm for emphysematous pyelonephritis: can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy? Int Urol Nephrol 49(12):2127–2136. https://doi.org/10.1007/s11255-017-1706-8

    Article  PubMed  Google Scholar 

  11. Olvera-Posada D, Armengod-Fischer G, Vázquez-Lavista LG, Maldonado-Avila M, Rosas-Nava E, Manzanilla-Garcia H, Castillejos-Molina RA, Mendez-Probst CE, Sotomayor M, Feria-Bernal G, Rodriguez-Covarrubias F (2014) Emphysematous pyelonephritis: Multicenter clinical and therapeutic experience in Mexico. Urology 83(6):1280–1284. https://doi.org/10.1016/j.urology.2014.02.010

    Article  PubMed  Google Scholar 

  12. Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, Pu YS (2014) Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis 14:418. https://doi.org/10.1186/1471-2334-14-418

    Article  PubMed  PubMed Central  Google Scholar 

  13. Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N’ Dow J, ABACUS research Group (2008) Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol 79(5):1844–1849. https://doi.org/10.1016/j.juro.2008.01.019

    Article  Google Scholar 

  14. Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, Somani B (2014) Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach. Arab J Urol 12(2):106–115. https://doi.org/10.1016/j.aju.2013.09.005

    Article  PubMed  Google Scholar 

  15. Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Leiskovsky G, Skinner DG (1985) Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol 134(6):1086–1088

    Article  CAS  Google Scholar 

  16. Das D, Pal DK (2016) Double J stenting: A rewarding option in the management of emphysematous pyelonephritis. Urol Ann 8(3):261–264. https://doi.org/10.4103/0974-7796.184881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lin WC, Chen YF, Lin CH, Ho YJ, Tzeng YH, Chiang HJ, Chang CH, Cheng YC, Shen WC, Chen JH (2009) Reappraisal of the management and outcome of emphysematous pyelonephritis. Kaohsiung J Med Sci 25(1):16–24. https://doi.org/10.1016/S1607-551X(09)70035-X

    Article  PubMed  Google Scholar 

  18. Shokeir AA, El-Azab M, Mohsen T, El-Diasty T (1997) Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology 49(3):343–346. https://doi.org/10.1016/S0090-4295(96)00501-8

    Article  CAS  PubMed  Google Scholar 

  19. Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, Lee SSJ, Liu YC (2001) Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect 34(2):125–130

    CAS  PubMed  Google Scholar 

  20. Kuo YT, Chen MT, Liu GC, Huang CN, Huang CL, Huang CH (1999) Emphysematous pyelonephritis: imaging diagnosis and follow-up. Kaohsiung J Med Sci 15(3):159–170

    CAS  PubMed  Google Scholar 

  21. Pontin AR, Barnes RD, Joffe J, Kahn D (1995) Emphysematous pyelonephritis in diabetic patients. Br J Urol 75(1):71–74. https://doi.org/10.1111/j.1464-410x.1995.tb07237

    Article  CAS  PubMed  Google Scholar 

  22. Park BS, Lee SJ, Kim YW, Huh JS, Kim JI, Chang SG (2006) Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol 40(4):332–338. https://doi.org/10.1080/00365590600794902

    Article  PubMed  Google Scholar 

  23. El-Nahas AR, Shokeir AA, Eziyi AK, Barakat TS, Tijani KH, El-Diasty T, Abol-Enein H (2011) Kidney preservation protocol for management of emphysematous pyelonephritis: Treatment modalities and follow-up. Arab J Urol 9(3):185–189. https://doi.org/10.1016/j.aju.2011.09.002

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wang JM, Lim HK, Pang KK (2007) Emphysematous pyelonephritis. Scand J Urol Nephrol 41(3):223–229. https://doi.org/10.1080/00365590601017451

    Article  CAS  PubMed  Google Scholar 

  25. Dhabalia JV, Nelivigi GG, Kumar V, Gokhale A, Punia MS, Pujari N (2010) Emphysematous pyelonephritis: tertiary care center experience in management and review of the literature. Urol Int 85(3):304–308. https://doi.org/10.1159/000315056

    Article  PubMed  Google Scholar 

  26. Eswarappa M, Suryadevara S, John MM, Kumar M, Reddy SB, Suhail M (2017) Emphysematous pyelonephritis: case series from south India. Kidney Int Rep 3(4):950–955. https://doi.org/10.1016/j.ekir.2017.12.003

    Article  PubMed  PubMed Central  Google Scholar 

  27. Adapala RR, Shetty R, Venugopal P, Prabhu GGL, Yalla D, Unnikrishnan B (2020) Renal salvage, an achievable goal in patients with emphysematous pyelonephritis: outcomes of an algorithmic renal preserving strategy. Urol Ann 12(2):156–162. https://doi.org/10.4103/UA.UA_67_19

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kamath SU, Patil B, Shelke U, Patwardhan SK (2019) Comparing diabetic and nondiabetic emphysematous pyelonephritis and evaluating predictors of mortality. Saudi J Kidney Dis Transpl 30(6):1266–1275. https://doi.org/10.4103/1319-2442.275470

    Article  PubMed  Google Scholar 

  29. Puvvada S, Arjun N, Mylarappa P, Gowda RD (2018) A prospective analysis of emphysematous pyelonephritis at a tertiary care centre. J Clin Urol 11(6):398–402. https://doi.org/10.1177/2051415817752854

    Article  Google Scholar 

  30. Misgar RA, Mubarik I, Wani AI, Bashir MI, Ramzan M, Laway BA (2016) Emphysematous pyelonephritis: a 10-year experience with 26 cases. Indian J Endocrinol Metab 20(4):475–480. https://doi.org/10.4103/2230-8210.183475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Fatima R, Jha R, Muthukrishnan J, Gude D, Nath V, Shekhar S, Narayan G, Sinha S, Mandal SN, Srinivas Rao B, Ramsubbarayudu B (2013) Emphysematous pyelonephritis: a single center study. Indian J Nephrol 23(2):119–124. https://doi.org/10.4103/0971-4065.109418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Elawdy MM, Osman Y, Abouelkheir RT, El-Halwagy S, Awad B, El-Mekresh M (2019) Emphysematous pyelonephritis treatment strategies in correlation to the CT classification: have the current experience and prognosis changed? Int Urol Nephrol 51(10):1709–1713. https://doi.org/10.1007/s11255-019-02220-3

    Article  CAS  PubMed  Google Scholar 

  33. Sokhal AK, Kumar M, Purkait B, Jhanwar A, Singh K, Bansal A, Sankhwar S (2017) Emphysematous pyelonephritis: changing trend of clinical spectrum, pathogenesis, management and outcome. Turk J Urol 43(2):202–209. https://doi.org/10.5152/tud.2016.14227

    Article  PubMed  PubMed Central  Google Scholar 

  34. Irfaan AM, Shaikh NA, Jamshaid A, Qureshi AH (2020) Emphysematous pyelonephritis: a single center review. Pak J Med Sci 36(1):S83–S86. https://doi.org/10.12669/pjms.36.ICON-Suppl.1728

    Article  PubMed  PubMed Central  Google Scholar 

  35. Karthikeyan VS, Manohar CMS, Mallya A, Keshavamurthy R, Kamath AJ (2018) Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis. Cent Eur J Urol 71(2):228–233. https://doi.org/10.5173/ceju.2018.1639

    Article  Google Scholar 

  36. Sharma PK, Sharma R, Vijay MK, Tiwari P, Goel A, Kundu AK (2013) Emphysematous pyelonephritis: our experience with conservative management in 14 cases. Urol Ann 5(3):157–162. https://doi.org/10.4103/0974-7796.115734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bjurlin MA, Hurley SD, Kim DY, Cohn MR, Jordan MD, Kim R, Divakaruni N, Hollowell CMP (2012) Clinical outcomes of nonoperative management in emphysematous urinary tract infections. Urology 79(6):1281–1285. https://doi.org/10.1016/j.urology.2012.02.023

    Article  PubMed  Google Scholar 

  38. Kuzgunbay B, Turunc T, Tokmak N, Turunc T, Dirim A, Aygun C, Ozkardes H (2011) Tailored treatment approach for emphysematous pyelonephritis. Urol Int 86(4):444–447. https://doi.org/10.1159/000323604 (Epub 2011 Apr 20 PMID: 21508616)

    Article  PubMed  Google Scholar 

  39. Lin YC, Lin YC, Lin HD, Lin LY (2012) Risk factors of renal failure and severe complications in patients with emphysematous pyelonephritis-a single-center 15-year experience. Am J Med Sci 343(3):186–191. https://doi.org/10.1097/MAJ.0b013e318225b891

    Article  PubMed  Google Scholar 

  40. Kuo CY, Lin CY, Chen TC, Lin WR, Lu PL, Tsai JJ, Chang K, Hsieh HC, Chen YH (2009) Clinical features and prognostic factors of emphysematous urinary tract infection. J Microbiol Immunol Infect 42(5):393–400

    CAS  PubMed  Google Scholar 

  41. Sanford TH, Myers F, Chi T, Bagga HS, Taylor AG, Stoller ML (2016) Emphysematous pyelonephritis: the impact of urolithiasis on disease severity. Transl Androl Urol 5(5):774–779. https://doi.org/10.21037/tau.2016.07.02

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Paul Bassett of Statsconsultancy Ltd, 40 Longwood Lane, Amersham, HP7 9EN, UK for help with the statistical analysis

Author information

Authors and Affiliations

  1. Department of Urology, London North West University Healthcare NHS Trust, Watford Road, Harrow, London, HA1 3UJ, UK

    Rajeev Desai & Deepak Batura

Authors
  1. Rajeev Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deepak Batura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deepak Batura.

Ethics declarations

Conflict of interest

The authors declare they have no conflicts of interest in this study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Human and animal rights

This article does not contain any studies with animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desai, R., Batura, D. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis. Int Urol Nephrol 54, 717–736 (2022). https://doi.org/10.1007/s11255-022-03131-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03131-6

Keywords

Search

Navigation